Exploring marine-derived compounds as potential anti-cancer agents: Mechanisms and therapeutic implications

Area of Science:

• Marine Biotechnology
• Natural Products Chemistry
• Oncology

Background:

• Marine organisms are rich sources of structurally diverse bioactive molecules.
• Marine-derived compounds exhibit potent anti-cancer properties and diverse mechanisms of action.
• Approved drugs demonstrate the clinical potential of marine natural products in cancer treatment.

Purpose of the Study:

• To review marine-derived anti-cancer compounds, their mechanisms, and clinical development.
• To highlight advances in discovery, production, and delivery of these compounds.
• To identify future directions for harnessing marine pharmacopeia in oncology.

Main Methods:

• Comprehensive literature review of marine-derived anti-cancer agents.
• Analysis of compound classes, mechanisms of action, and clinical applications.
• Evaluation of biotechnological advances and drug delivery systems.

Main Results:

• Marine compounds target apoptosis, angiogenesis, cell cycle, and signaling pathways.
• Key compound classes include alkaloids, polysaccharides, peptides, terpenoids, and polyketides.
• Approved drugs (e.g., trabectedin) and ongoing research show significant therapeutic potential.

Conclusions:

• Marine natural products represent a vital resource for novel anti-cancer drug discovery.
• Biotechnology and advanced delivery systems are crucial for overcoming production and bioavailability challenges.
• Further research into molecular targets and synergistic therapies is essential for maximizing clinical impact.